Dianthus Therapeutics, Inc. (DNTH)
102.49
-2.28
(-2.18%)
USD |
NASDAQ |
Sep 16, 16:00
102.49
0.00 (0.00%)
After-Hours: 17:17
Dianthus Therapeutics Market Cap : 5.616B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 5.741B |
| September 14, 2026 | 5.901B |
| September 11, 2026 | 5.820B |
| September 10, 2026 | 5.660B |
| September 09, 2026 | 5.866B |
| September 08, 2026 | 5.980B |
| September 04, 2026 | 5.924B |
| September 03, 2026 | 5.910B |
| September 02, 2026 | 5.822B |
| September 01, 2026 | 5.843B |
| August 31, 2026 | 5.787B |
| August 28, 2026 | 5.800B |
| August 27, 2026 | 6.112B |
| August 26, 2026 | 6.069B |
| August 25, 2026 | 6.143B |
| August 24, 2026 | 6.032B |
| August 21, 2026 | 6.088B |
| August 20, 2026 | 6.001B |
| August 19, 2026 | 6.231B |
| August 18, 2026 | 6.331B |
| August 17, 2026 | 6.294B |
| August 14, 2026 | 6.354B |
| August 13, 2026 | 6.006B |
| August 12, 2026 | 6.160B |
| August 11, 2026 | 5.945B |
| Date | Value |
|---|---|
| August 10, 2026 | 6.126B |
| August 07, 2026 | 5.969B |
| August 06, 2026 | 6.023B |
| August 05, 2026 | 6.165B |
| August 04, 2026 | 6.050B |
| August 03, 2026 | 5.810B |
| July 31, 2026 | 5.836B |
| July 30, 2026 | 6.148B |
| July 29, 2026 | 5.682B |
| July 28, 2026 | 5.546B |
| July 27, 2026 | 5.703B |
| July 24, 2026 | 5.670B |
| July 23, 2026 | 5.720B |
| July 22, 2026 | 5.609B |
| July 21, 2026 | 5.770B |
| July 20, 2026 | 5.513B |
| July 17, 2026 | 5.764B |
| July 16, 2026 | 5.204B |
| July 15, 2026 | 5.453B |
| July 14, 2026 | 5.528B |
| July 13, 2026 | 5.384B |
| July 10, 2026 | 5.327B |
| July 09, 2026 | 5.460B |
| July 08, 2026 | 5.353B |
| July 07, 2026 | 5.227B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Verastem, Inc. | 663.68M |
| AbbVie, Inc. | 464.00B |
| TG Therapeutics, Inc. | 8.540B |
| Krystal Biotech, Inc. | 9.961B |
| Legend Biotech Corp. | 3.294B |
Market Cap Related Metrics
| PS Ratio | 2514.17 |
| PEG Ratio | -0.8954 |
| Price to Book Value | 4.792 |
| Price | 102.49 |
| Earnings Yield | -4.05% |
| PEGY Ratio | -0.8954 |